Jump to content

Oral cavity and oropharynx cancer: Difference between revisions

no edit summary
No edit summary
No edit summary
 
Line 26: Line 26:
Oropharyngeal cancer is moderately radiosensitive. For this reason, radiochemotherapy is the preferred modality, but surgery is an option.
Oropharyngeal cancer is moderately radiosensitive. For this reason, radiochemotherapy is the preferred modality, but surgery is an option.
<section end="oncology" /><noinclude>‎
<section end="oncology" /><noinclude>‎
[[Category:Ear, nose, throat (ENT)]]
[[Category:Ear, nose, throat (ENT)]][[Category:Oncology]]
</noinclude>
</noinclude>